Cathay Biotech Inc (688065) — Capital Reinvestment Ratio
Cathay Biotech Inc (688065) has a Capital Reinvestment Ratio of 0.31x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥251.82 Million) in capital expenditures (CN¥78.51 Million). Check Cathay Biotech Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cathay Biotech Inc Capital Reinvestment Ratio (2017–2025)
This chart tracks Cathay Biotech Inc's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see 688065 cash flow metrics.
Annual Capital Reinvestment Ratio for Cathay Biotech Inc (2017–2025)
Year-by-year Capital Reinvestment Ratio for Cathay Biotech Inc from 2017 to 2025. See 688065 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.84x | CN¥404.12 Million | CN¥743.46 Million | ▲ +79.1% |
| 2024 | 1.03x | CN¥820.93 Million | CN¥843.31 Million | ▼ -62.7% |
| 2023 | 2.76x | CN¥569.45 Million | CN¥1.57 Billion | ▼ -47.2% |
| 2022 | 5.22x | CN¥803.67 Million | CN¥4.20 Billion | ▲ +110.5% |
| 2021 | 2.48x | CN¥594.18 Million | CN¥1.47 Billion | ▲ +67.5% |
| 2020 | 1.48x | CN¥514.96 Million | CN¥763.11 Million | ▲ +4.3% |
| 2019 | 1.42x | CN¥359.62 Million | CN¥511.14 Million | ▼ -92.4% |
| 2017 | 18.62x | CN¥53.45 Million | CN¥995.09 Million | — |